WilmerHale Represents General Catalyst Partners in its Series E Preferred Stock Investment in Olive

WilmerHale Represents General Catalyst Partners in its Series E Preferred Stock Investment in Olive

Client News

Related Solutions

Helping clients launch their businesses and transform their innovative ideas into successful companies.

WilmerHale represented General Catalyst Partners in its Series E preferred stock investment in Olive, a company creating AI workforce for healthcare. On March 31, 2020, Olive announced the closing of its $51 million funding round led by General Catalyst, which will enable Olive to accelerate its growth and further its mission of automating healthcare’s administrative processes so hospital employees can focus on delivering high-quality, cost-effective care. Drive Capital, Oak HC/FT, Ascension Ventures and several others also participated in the financing.

The WilmerHale team representing General Catalyst consisted of Jason Kropp, Mark Nylen, and Korey Cowan, with assistance from Kirk Nahra, Kim Wethly, Ciara Baker, Ariel Soiffer and Ali Jessani.

Read the press release for more information.

Notice

We appreciate your interest in WilmerHale. While we are pleased to have you contact us, please keep in mind that merely contacting WilmerHale does not create an attorney-client relationship. Such a relationship will not arise until the Firm agrees in writing to represent you in connection with a particular matter. Importantly, unless and until this has occurred, you should not provide us with any confidential information, and we have no duty to keep confidential any information that we may receive from you. Thank you for your understanding.

I Accept Cancel